Avaleht › Pea ja kaela lameepiteeli kartsinoom › Illinois

Pea ja kaela lameepiteeli kartsinoom kliinilised uuringud osariigis Illinois

30 uuringut haiguse Pea ja kaela lameepiteeli kartsinoom jaoks otsivad osalejaid osariigis Illinois.

Linnad osariigis Illinois

Ametlik uuringutekst (inglise keeles)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
ja veel 39

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06992427

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago

VärbamineFaas 2/3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06788990

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Chicago Hospital, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06465069

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #26, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Advocate Good Shepherd Hospital, Barrington
University of Chicago Comprehensive Cancer Center, Chicago
Advocate Illinois Masonic Medical Center, Chicago
ja veel 29

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Rush-Copley Medical Center, Aurora
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
ja veel 38

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT05136196

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Rush University Medical Center Rush University Cancer Center Chicago, Chicago
The University of Chicago Medical Center (UCMC), Chicago
Cancer Care Specialists of Central Illinois, O'Fallon

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

The University of Chicago Medical Center (UCMC), Chicago

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT06385080

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Northwestern University, Chicago
John H Stroger Jr Hospital of Cook County, Chicago
University of Illinois, Chicago
ja veel 14

VärbamineFaas 2

Vanused 18–79 · Kõik sood · Uuendatud 22. sept 2026 · NCT04671667

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Northwestern University Feinberg School of Medicine, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. sept 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Chicago, Zion

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. sept 2026 · NCT07109726

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Good Shepherd Hospital, Barrington
ja veel 53

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT02734537

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Northwestern University Feinberg School of Medicine, Chicago
Cancer Care Specialists of Illinois, Decatur
Illinois Cancer Care, Peoria

VärbamineVaatlusuuring

Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT06163534

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Northwestern University, Evanston

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. aug 2026 · NCT06769698

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

University of Chicago Medical Center /ID# 276638, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 19. aug 2026 · NCT07241039

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Northwestern University, Chicago
Rush MD Anderson Cancer Center, Chicago

VärbamineFaas 2/3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

OSF Saint Joseph Medical Center, Bloomington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
ja veel 21

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT06532279

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

OSF Saint Joseph Medical Center, Bloomington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
ja veel 22

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT07441681

SMP-3124LP in Adults With Advanced Solid Tumors

Northwestern Medicine Cancer Center, Chicago
The University of Chicago, Chicago

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 12. aug 2026 · NCT06526819

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Orchard Healthcare Research Inc, Skokie

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. aug 2026 · NCT06330064

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ingalls Family Care Center, Calumet City
UChicago Medicine - River East, Chicago
The University Of Chicago, Chicago
ja veel 13

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 6. juuli 2026 · NCT04389632

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

The University of Chicago Medical Center - Oncology, Chicago

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. juuni 2026 · NCT06747585

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
University of Chicago Medical Center /ID# 276271, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. juuni 2026 · NCT05005403

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

University of Chicago Comprehensive Cancer Center, Chicago

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 12. mai 2026 · NCT05420948

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

The University of Chicago, Chicago

VärbamineFaas 2/3

Vanused 18–100 · Kõik sood · Uuendatud 23. apr 2026 · NCT05893888

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

University of Illinois Cancer Center, Chicago

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. apr 2026 · NCT06064877

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

The University of Chicago, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. märts 2026 · NCT05526924

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

The University of Chicago Comprehensive Cancer Center, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. veebr 2026 · NCT06778863

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Kellogg Cancer Center, Evanston

VärbamineFaas 1/2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. nov 2025 · NCT05902988

A Study of NX-1607 in Adults With Advanced Malignancies

University of Chicago, Chicago

VärbamineFaas 1

Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2025 · NCT05107674

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.